Tutkimus Virran viisivuotisen tutkimusprojektin aineistosta kahden vuoden kohdalta.
Masennusoireet vähenivät 10 ensimmäisen ketoiluviikon aikana ja pysyivät alentuneella tasollaan tutkimusjakson loppuun asti.https://link.springer.com/article/10.10 ... 21-00272-4
Published: 27 January 2022
Depressive symptoms improve over 2 years of type 2 diabetes treatment via a digital continuous remote care intervention focused on carbohydrate restriction
Rebecca N. Adams, Shaminie J. Athinarayanan, Amy L. McKenzie, Sarah J. Hallberg, James P. McCarter, Stephen D. Phinney & Jeffrey S. Gonzalez
Journal of Behavioral Medicine (2022)Cite this article
Depressive symptoms are prevalent among people with type 2 diabetes (T2D) and, even at low severity levels, are associated with worse diabetes outcomes. Carbohydrate restriction is an effective treatment for T2D but its long-term impacts on depressive symptoms are unclear. In the current study we explored changes in depressive symptoms over 2 years among 262 primarily non-depressed T2D patients participating in a continuous remote care intervention emphasizing carbohydrate restriction. Subclinical depressive symptoms decreased over the first 10 weeks and reductions were maintained out to 2 years. Increased frequency of blood ketone levels indicative of adherence to low carbohydrate eating predicted decreases in depressive symptoms. Concerns have been raised with recommending restrictive diets due to potential negative impacts on quality-of-life factors such as mood; however, results of the current study support positive rather than negative long-term impacts of closely monitored carbohydrate restriction on depressive symptoms.